Margaret Readio

Margaret is the Director of Technical Development Operations at GentiBio. Margaret has worked in multiple roles across her 20+ years in the industry, including process and analytical development and GMP manufacturing and Quality Control of oligonucleotide and protein therapeutics, and more recently 6+ years of cell therapy development at Juno/Celgene/Bristol Myers-Squibb. Her work at Juno supported the Biologics License Application and approval of the Breyanzi CAR-T cell therapy product. In her most recent role at Bristol Meyers Squibb, Margaret led the Development Operations team that supported pipeline development, laboratory operations, and commercial raw material testing for CAR-T products. Margaret grew up in Boulder, CO, and obtained a BS in Chemical Engineering from the University of Colorado.